
Can this nasal spray slow down Alzheimer’s? One couple is helping scientists find out
Joe Walsh, who has Alzheimer’s disease, is accompanied by his wife, Karen Walsh, to an appointment at Brigham and Women’s
Latest News From:
:أخر الأخبار من

Joe Walsh, who has Alzheimer’s disease, is accompanied by his wife, Karen Walsh, to an appointment at Brigham and Women’s

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the disease in the United States. The test, called the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, is for adults 55 and …
The post FDA greenlights first blood test to help diagnose Alzheimer’s disease in the US appeared first on Egypt Independent.

Ione and Doug Whitney, February, 2025. Megan Farmer, WashU Medicine Megan Farmer, WashU Medicine People who inherit one very rare

Acclaimed Egyptian actress and media personality Ismad Younes has announced the decision to re-release Adel Imam’s 2010 film “Alzheimer” in Egyptian and Gulf cinemas, marking the iconic actor’s return to the big screen after years of absence from the competitive cinematic landscape. Starting from May 16, the film will be screened for three consecutive days, …
The post Adel Imam’s ‘Alzheimer’ to return to the silver screen for three days in May appeared first on Egypt Independent.

A drug that has been shown to stall the symptoms of Alzheimer’s is being hailed as a turning point in treatment of the distressing disease. The experimental drug donanemab changed … Continued
The post ‘Major breakthrough’ hailed in Alzheimer’s treatment appeared first on The New Daily.

CNN — The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease. The Centers for Medicare and Medicaid Services said Thursday that it will now expand coverage of the drug, broadening access for up to an estimated …
The post First Alzheimer’s drug to slow disease progression gets full FDA approval, triggering broader Medicare coverage appeared first on Egypt Independent.